Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Patients With Atrial Fibrillation At Greater Risk Of Death In Rural Hospitals Than Urban Hospitals

December 28, 2017 By Elsevier

Patients with atrial fibrillation (AF) admitted to rural hospitals in the U.S. have a greater chance of dying during their hospital stay than patients admitted to urban hospitals for the same condition, according to a new report in HeartRhythm.

AF is a common problem, consisting of skipped or irregular heartbeats (arrhythmias) that can lead to blood clots, stroke, heart failure, and other cardiovascular complications. Left untreated, AF doubles the risk of heart-related deaths and is associated with a five-fold increased risk for stroke, according to the American Heart Association.

“The identification of healthcare disparities is of utmost importance at this time to improve the overall care that is delivered in our healthcare system,” explains lead investigator Wesley T. O’Neal, MD, MPH, of the Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA. “Our research shows that urban-rural differences exist regarding the risk of hospital mortality among patients who are admitted for AF.”

Investigators used data from the National Inpatient Sample (NIS), a database representative of discharged patients from U.S. community hospitals, to compare the in-hospital mortality of patients admitted for AF in rural versus urban hospitals. The NIS approximates a 20 percent stratified sample of all discharges and excludes rehabilitation and long-term acute care hospitals. The data are drawn from 44 states, plus the District of Columbia, representing more than 96 percent of the United States population. The analysis employed a cross-sectional examination of the NIS database of AF hospitalizations between 2012 and 2014 to determine if admission to a rural hospital was associated with an increased risk of in-hospital mortality compared with patients admitted to urban hospitals.

Looking at death due to any cause during hospitalization of patients with AF, the study found that patients admitted to rural hospitals had a 17 percent increased risk of death during hospitalization compared with urban hospitals. Analysis accounted for differences in patient characteristics and potential confounders. The five most common secondary diagnoses for patients hospitalized for AF were heart failure, hypertension, hyperlipidemia, diabetes, and acute kidney injury.

“Since we have identified rural hospitals as locations where in-hospital mortality for atrial fibrillation admission is possibly higher than other areas of the country, our findings will drive future research endeavors to uncover the reasons for this difference, and to develop strategies to improve the medical care for patients with this heart rhythm disturbance,” O’Neal concludes.

Although the reasons for this difference are unclear at this time, these data likely are of interest to providers and policy makers who are working towards the reduction of mortality in rural regions.

In an accompanying editorial, Thomas F. Deering, MD, FHRS, and Ashish A. Bhimani, MD, FHRS, both from the Arrhythmia Center, Piedmont Heart Institute, Atlanta, GA, commend O’Neal et al for their detailed analysis, increasing awareness in the medical community about a potentially important arrhythmic healthcare issue, and placing their findings into the appropriate context. They also point out that the study raises important clinical and epidemiological questions.

They stress that factors such as associated comorbidities and their severity, access to care, patient lifestyle decisions, patient compliance, physician adherence to diagnostic and therapeutic guideline recommendations, physician referral patterns, etc., which may have contributed to the observed outcomes, remain unknown.

“Accordingly, claims-based analyses, such as these, should be viewed as hypothesis-generating instead of categorical in nature. The electrophysiology and medical communities should look at the findings presented in this study as a motivational call to initiate prospective studies with the goal of identifying gaps in AF care, which can then be used to create effective healthcare policies, designed to reduce AF-related mortality,” comments Deering and Bhimani.

Related Articles Read More >

Wire mesh that has captured a blood clot
How an Embotrap stent retriever thrombectomy treats ischemic strokes
A team of doctors use the Hemafuse device to collect and filter a surgery patient's blood
Autotranfusion device maker ships units to Ukraine
A close-up photo of a human eye
Proposed 2023 Medicare Physician Fee Schedule could have a big impact on glaucoma surgeries
Avail Medsystems
How Avail Medsystems seeks to create a connected OR experience

DeviceTalks Weekly.

August 5, 2022
DTW Medtronic's Greg Smith lays out supply chain strategies
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech